Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10922979rdf:typepubmed:Citationlld:pubmed
pubmed-article:10922979lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:10922979lifeskim:mentionsumls-concept:C0035067lld:lifeskim
pubmed-article:10922979lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:10922979pubmed:dateCreated2000-9-20lld:pubmed
pubmed-article:10922979pubmed:abstractTextRenal artery stenosis (RAS) was searched for in a Type 2 diabetes population (n =208) with severe hypertension (SHT) and/or renal deficiency (RD) and/or severe macroangiopathy (MA), using arteriography and/or duplex colour scan (with confirmation by arteriography or magnetic resonance angiography). Thirty-four (16.3 %) cases had significant RAS >=70% (83% unilateral, 17% bilateral; 11.7% with total thrombosis). High significance (P<0.01) (34 RAS vs 174 subjects without RAS) was found for male predominance (sex ratio 0.8), smoking (47%), insulin requirement (65%), prevalence and severity of decreased renal function (65%), severe hypertension (53%), and prevalence of macroangiopathy (82%), especially in association with coronary heart disease (65%). RAS prevalence was low in subjects with only 1 (8%) diagnostic criterion and high when 2 (21%) or 3 (41%) signs were present, regardless of the criterion (HT/RD/MA). A high increase of RAS prevalence was found in males, smokers and patients with heart disease or macroalbuminuria when 2 or 3 diagnostic criteria were present (no increased prevalence for only 1 criterion). RAS screening should be performed in a Type 2 diabetic population with HT, RD, or MA by opacification of the renal arteries at the same time as arteriography for control of another vessel, or by duplex colour scan when 2 or 3 diagnostic criteria are present. This attitude allows a diagnostic score of 85 % of RAS in this Type 2 diabetic population.lld:pubmed
pubmed-article:10922979pubmed:languageenglld:pubmed
pubmed-article:10922979pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10922979pubmed:citationSubsetIMlld:pubmed
pubmed-article:10922979pubmed:statusMEDLINElld:pubmed
pubmed-article:10922979pubmed:monthJullld:pubmed
pubmed-article:10922979pubmed:issn1262-3636lld:pubmed
pubmed-article:10922979pubmed:authorpubmed-author:CourrègesJ...lld:pubmed
pubmed-article:10922979pubmed:authorpubmed-author:PradierPPlld:pubmed
pubmed-article:10922979pubmed:authorpubmed-author:AboudEElld:pubmed
pubmed-article:10922979pubmed:authorpubmed-author:BachaJJlld:pubmed
pubmed-article:10922979pubmed:issnTypePrintlld:pubmed
pubmed-article:10922979pubmed:volume26 Suppl 4lld:pubmed
pubmed-article:10922979pubmed:ownerNLMlld:pubmed
pubmed-article:10922979pubmed:authorsCompleteYlld:pubmed
pubmed-article:10922979pubmed:pagination90-6lld:pubmed
pubmed-article:10922979pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:meshHeadingpubmed-meshheading:10922979...lld:pubmed
pubmed-article:10922979pubmed:year2000lld:pubmed
pubmed-article:10922979pubmed:articleTitlePrevalence of renal artery stenosis in type 2 diabetes.lld:pubmed
pubmed-article:10922979pubmed:affiliationDiabetology and Vascular Disease Unit, General Hospital, Narbonne, France.lld:pubmed
pubmed-article:10922979pubmed:publicationTypeJournal Articlelld:pubmed